Jpmorgan Chase & CO Frequency Therapeutics, Inc. Transaction History

Jpmorgan Chase & CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.35 - $0.72 $15 - $31	44 Added 7.77%	610 $0
Q4 2022 Feb 13, 2023	SELL	$1.88 - $3.85 $2,688 - $5,505	-1,430 Reduced 71.64%	566 $2,000
Q3 2022 Nov 14, 2022	BUY	$1.46 - $2.55 $1,042 - $1,820	714 Added 55.69%	1,996 $4,000
Q2 2022 Aug 11, 2022	SELL	$1.03 - $2.03 $1.08 Million - $2.13 Million	-1,049,957 Reduced 99.88%	1,282 $2,000
Q1 2022 May 11, 2022	SELL	$1.7 - $5.72 $197,604 - $664,881	-116,238 Reduced 9.96%	1,051,239 $2.23 Million
Q4 2021 Feb 10, 2022	SELL	$4.95 - $7.11 $572,660 - $822,548	-115,689 Reduced 9.02%	1,167,477 $5.99 Million
Q3 2021 Nov 12, 2021	BUY	$6.96 - $9.25 $8.93 Million - $11.9 Million	1,283,166 New	1,283,166 $9.06 Million

Ticker FREQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,262,000
Description
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candi...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.